Comparative Oncology Today - 08/08/11
Doi : 10.1016/j.cvsm.2007.08.003
Melissa C. Paoloni, DVM, Chand Khanna, DVM, PhD ⁎ 
Comparative Oncology Program, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2144, Bethesda, MD 20892, USA
Corresponding author.Abstract |
The value of comparative oncology has been increasingly recognized in the field of cancer research, including the identification of cancer-associated genes; the study of environmental risk factors, tumor biology, and progression; and, perhaps most importantly, the evaluation of novel cancer therapeutics. The fruits of this effort are expected to be the creation of better and more specific drugs to benefit veterinary and human patients who have cancer. The state of the comparative oncology field is outlined in this article, with an emphasis on cancer in dogs.
Le texte complet de cet article est disponible en PDF.Plan
© 2007
Publié par Elsevier Masson SAS.
Vol 37 - N° 6
P. 1023-1032 - novembre 2007 Retour au numéro
Article précédent
- Communicating with Oncology Clients
- Ruthanne Chun, Laura D. Garrett
- Cancer Clinical Trials: Development and Implementation
- David M. Vail
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?